Effect of chlorpromazine on the oxygen consumption of puppies

  • V. D. Rozanova
Pharmacology
  • 15 Downloads

Keywords

Oxygen Public Health Oxygen Consumption Chlorpromazine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. 1.
    I. A. Arshavskii, in the book: Neurohumoral Regulation in Ontogenesis [in Russian], Kiev (1964), p. 6.Google Scholar
  2. 2.
    O. T. Vakhidova, Analysis of Correlative Relationships between Energy Metabolism, Natural Respiration Rate, and Cardiac Activity of Dogs at Different Age Periods, Author's abstract of candidate dissertation, Moscow (1964).Google Scholar
  3. 3.
    O. T. Vakhidova, Byull. Éksp. Biol., No. 2, 32 (1965).Google Scholar
  4. 4.
    N. A. Kruglov, Uchen. Zapiski Inst. Farmakol. Khimioter. AMN SSSR,1, 59 (1958).Google Scholar
  5. 5.
    V. P. Lebedev, in the book: New Data on the Pharmacology of the Reticular Formation and Synaptic Transmission [in Russian], Leningrad (1958), p. 87.Google Scholar
  6. 6.
    M. D. Mashkovskii, S. S. Liberman, and A. I. Polezhaeva, Zh. Farmakol. Toksikol., No. 1, 14 (1955).Google Scholar
  7. 7.
    M. D. Mashkovskii and B. A. Medvedev, Byull. Éksp. Biol., No. 4, 50 (1956).Google Scholar
  8. 8.
    A. V. Nasedkin, Adrenergic Mechamisms of the Brain Structures of Rabbits in Ontogenesis and in Various Functional States, Author's abstract of candidate dissertation, Moscow (1962).Google Scholar
  9. 9.
    V. D. Rozanova, Byull. Éksp. Biol., No. 6, 62 (1959).Google Scholar
  10. 10.
    R. V. Chagovets, E. V. Lakhno, and A. A. Rybina, Zh. Farmakol. Toksikol., No. 1, 50 (1958).Google Scholar
  11. 11.
    I. N. Shchelovanova, Uchen. Zapiski Inst. Farmakol. Khimioter. AMN SSSR,1, 161 (1958).Google Scholar
  12. 12.
    L. G. Abood, Proc. Soc. Exp. Biol., (New York),88 (1955), p. 688.Google Scholar
  13. 13.
    A. Andrejew and A. J. Rosenberg, C. R. Soc. Biol.,150 (1956), p. 639.Google Scholar
  14. 14.
    J. Bernsohn, I. Namajuska, and L. S. G. Cochrane, Arch. Biochem.,62 (1956), p. 274.Google Scholar
  15. 15.
    J. Bernsohn, I. Namajuska, and B. Boshes, J. Neurochem.,1 (1956), p. 145.Google Scholar
  16. 16.
    M. Bourgeois-Gavardin, W. K. Nowill, G. Margolis, et al., Anesthesiology,16 (1955), p. 829.Google Scholar
  17. 17.
    W. Brendel and H. L'Allemand, Arch. Exp. Path. Pharmak., Bd 225, S 87 (1955).Google Scholar
  18. 18.
    S. Courvoisier, et al., Arch. Int. Pharmacodyn.,92 (1953), p. 305.Google Scholar
  19. 19.
    Ph. Decourt, Therapie,8 (1953), p. 846.Google Scholar
  20. 20.
    Ph. Decourt, Therapie, C. R. Acad. Sci. (Paris),236 (1953), p. 1195.Google Scholar
  21. 21.
    J. Ducuing and J. Rieunau-Serra, Mém. Acad. Chir.,79 (1953), p. 414.Google Scholar
  22. 22.
    K. Feller, Arch. Exp. Path. Pharmak., Bd 225, S. 90 (1955).Google Scholar
  23. 23.
    M. Finkelstein, W. A. Spencer, and E. R. Ridway, Proc. Soc. Exp. Biol., New York,87 (1954), p. 343.Google Scholar
  24. 24.
    B. Grad, Endocrinology,50 (1952), p. 94.Google Scholar
  25. 25.
    L. Peruzzo, Presse Méd.,61 (1953), p. 1463.Google Scholar
  26. 26.
    A. W. Wase, J. Christensen, and E. H. Polley, Arch. Neurol. Psychiat.,75 (1956), p. 54.Google Scholar
  27. 27.
    G. Werner, Wien. Klin. Wschr., Bd. 66, S. 966 (1954).Google Scholar

Copyright information

© Consultants Bureau 1968

Authors and Affiliations

  • V. D. Rozanova

There are no affiliations available

Personalised recommendations